Sinofn Health
Sinofn Health
Featured Formulations
Finland, a global leader in the Bioeconomy and Functional Foods, presents a sophisticated market for nutraceuticals. With a culture deeply rooted in "Sisu" and a high demand for preventative health measures, Finnish consumers prioritize clean-label, science-backed, and sustainably produced supplements.
As Finland addresses the needs of an aging demographic, the demand for bone health, cognitive support, and metabolic wellness products is at an all-time high.
Finnish brands require OEM partners who can adhere to strict EFSA (European Food Safety Authority) regulations while maintaining the "Natural" aesthetic essential for Northern Europe.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences. Established in 2025, we operate from Shanghai as the trading hub for global partners seeking premium, science-driven contract manufacturing services.
"We measure success not just in revenue, but in lives improved through accessible science."
During her clinical work, Mrs. Liu witnessed lifelong struggles of PKU (Phenylketonuria) children where specialized diets were financially out of reach. Driven to bridge this gap, she founded SINOFN in 2012 to develop affordable, science-backed PKU foods.
Building excellent product quality with an elite team from top global institutions.
Medical Innovation Director
Ph.D Peking University Medical School
15+ years in metabolic disorder formulations
R&D Lead
Associate Researcher, CAS Postdoc
Specialist in bioactive compound delivery systems
Formulation Director
Senior Scientist (Netherlands)
EU regulatory specialist in nutraceutical tech
We provide small-batch ODM services for Finnish startups focusing on DNA-based or biomarker-driven personalized supplement packs.
Aligning with Finland’s green initiatives, we offer biodegradable packaging and sustainably sourced raw materials for all OEM projects.
Utilizing delivery technologies like liposomal encapsulation to ensure maximum absorption—a key requirement for the premium Finnish pharmacy channel.
Ensuring safety from raw material to Finnish doorstep.
10+ dedicated lines (softgels, gummies, powders). ISO 22000, HACCP, FSSC 22000 certified. Annual capacity: 500M+ units.
HPLC/GC-MS contaminant screening, microbiological safety testing, and stability/dissolution validation in-house.
Pilot-scale prototyping for tablets, capsules, and liquids. Bioavailability optimization studies and stability testing chambers.
Full transparency from raw material storage to production and BRCGS-certified warehousing.
Our formulation team, led by Dutch expert Hans van Dijk, specializes in EU food safety regulations. We ensure all ingredients, dosages, and labeling meet Finnish and EU standards before shipment.
Yes. We have a dedicated pilot-scale R&D facility that allows for small-batch prototyping (as low as 500-1000 units) to test market viability in cities like Helsinki and Espoo.
Standard production takes 4-6 weeks. For shipping, we utilize the Sino-Europe Express Railway or premium sea freight, arriving in Finnish ports (Helsinki/Kotka) within 25-35 days depending on the mode.
Absolutely. SINOFN was founded on PKU research. We are one of the few global manufacturers capable of producing high-quality, affordable PKU foods for age-specific metabolic needs.
Advanced Formulations for Clinical and Performance Excellence
Partner with SINOFN for Unmatched Science, Safety, and Scale.
Send Inquiry Now
